Publications of Yvonne Genzel
All genres
Journal Article (105)
2018
Journal Article
36 (22), pp. 3140 - 3145 (2018)
Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells. Vaccine
Journal Article
102 (20), pp. 8725 - 8737 (2018)
Process intensification of EB66 ® cell cultivations leads to high-yield yellow fever and Zika virus production. Applied Microbiology and Biotechnology
Journal Article
9, 26 (2018)
Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution. Frontiers in Immunology
Journal Article
36 (22), pp. 3124 - 3133 (2018)
High-cell-density cultivations to increase MVA virus production. Vaccine
Journal Article
102 (3), pp. 1167 - 1177 (2018)
Cell culture-based production of defective interfering particles for influenza antiviral therapy. Applied Microbiology and Biotechnology 2017
Journal Article
12 (8), e0182553 (2017)
Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems. PLoS One 2016
Journal Article
11 (10), pp. 1332 - 1342 (2016)
Ezrin and HNRNP expression correlate with increased virus release rate and early onset of virus-induced apoptosis of MDCK suspension cells. Biotechnology Journal
Journal Article
113 (1), pp. 150 - 162 (2016)
Increased titer and reduced lactate accumulation in recombinant retrovirus production through the down-regulation of HIF1 and PDK. Biotechnology and Bioengineering
Journal Article
100 (5), pp. 2121 - 2132 (2016)
Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Applied Microbiology and Biotechnology 2015
Journal Article
99 (17), pp. 7059 - 7068 (2015)
Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells. Applied Microbiology and Biotechnology
Journal Article
14 (9), pp. 1181 - 1191 (2015)
Bioreactor concepts for cell culture-based viral vaccine production. Expert Review of Vaccines
Journal Article
10 (5), pp. 728 - 740 (2015)
Designing cell lines for viral vaccine production: Where do we stand? Biotechnology Journal
Journal Article
33 (35), pp. 4269 - 4280 (2015)
Monitoring changes in proteome during stepwise adaptation of a MDCK cell line from adherence to growth in suspension. Vaccine 2014
Journal Article
32 (24), pp. 2770 - 2781 (2014)
High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine
Journal Article
14, 72 (2014)
The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis. BMC Biotechnology
Journal Article
178, pp. 43 - 53 (2014)
The influence of cell growth and enzyme activity changes on intracellular metabolite dynamics in AGE1.HN.AAT cells. Journal of Biotechnology
Journal Article
98 (1), pp. 385 - 397 (2014)
Changes in intracellular metabolite pools during growth of adherent MDCK cells in two different media. Applied Microbiology and Biotechnology
Journal Article
32 (8), pp. 1003 - 1011 (2014)
Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine 2013
Journal Article
8 (9), e72288 (2013)
Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles. PLoS One
Journal Article
97 (1), pp. 111 - 122 (2013)
CAP, a new human suspension cell line for influenza virus production. Applied Microbiology and Biotechnology